523 related articles for article (PubMed ID: 31081082)
21. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
Wang YG; Wang T; Shi M; Zhai B
J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
[TBL] [Abstract][Full Text] [Related]
23. LINC00174 is an oncogenic lncRNA of hepatocellular carcinoma and regulates miR-320/S100A10 axis.
Zhao JT; Chi BJ; Sun Y; Chi NN; Zhang XM; Sun JB; Chen Y; Xia Y
Cell Biochem Funct; 2020 Oct; 38(7):859-869. PubMed ID: 32128852
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis.
Liao Z; Zhang H; Su C; Liu F; Liu Y; Song J; Zhu H; Fan Y; Zhang X; Dong W; Chen X; Liang H; Zhang B
J Exp Clin Cancer Res; 2021 Jan; 40(1):36. PubMed ID: 33485374
[TBL] [Abstract][Full Text] [Related]
26. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.
Yin J; Liu Q; Chen C; Liu W
J Cell Physiol; 2019 Aug; 234(10):17589-17599. PubMed ID: 30825207
[TBL] [Abstract][Full Text] [Related]
27. The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma.
Han QL; Chen BT; Zhang KJ; Xia ST; Zhong WW; Zhao ZM
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2013-2019. PubMed ID: 30915744
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer.
Huang HG; Tang XL; Huang XS; Zhou L; Hao YG; Zheng YF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4232-4245. PubMed ID: 32373959
[TBL] [Abstract][Full Text] [Related]
29. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
30. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2.
Ding J; Yang C; Yang S
J Oral Pathol Med; 2018 May; 47(5):468-476. PubMed ID: 29315846
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
32. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
[TBL] [Abstract][Full Text] [Related]
33. LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c.
Xue S; Lu F; Sun C; Zhao J; Zhen H; Li X
World J Surg Oncol; 2021 Apr; 19(1):121. PubMed ID: 33865414
[TBL] [Abstract][Full Text] [Related]
34. RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway.
Li J; Xia T; Cao J; He D; Chen Z; Liang B; Song J
Aging (Albany NY); 2020 Jul; 12(14):14918-14932. PubMed ID: 32687483
[TBL] [Abstract][Full Text] [Related]
35. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721.
Liu RT; Cao JL; Yan CQ; Wang Y; An CJ; Lv HT
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143959
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
[TBL] [Abstract][Full Text] [Related]
37. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway.
Li X; Cheng T; He Y; Zhou S; Wang Y; Zhang K; Yu P
Life Sci; 2019 Sep; 232():116602. PubMed ID: 31251997
[TBL] [Abstract][Full Text] [Related]
38. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
[TBL] [Abstract][Full Text] [Related]
39. LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma.
Zhou Y; Fan RG; Qin CL; Jia J; Wu XD; Zha WZ
Genomics; 2019 Dec; 111(6):1862-1872. PubMed ID: 30543848
[TBL] [Abstract][Full Text] [Related]
40. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
Liu Z; Chen JY; Zhong Y; Xie L; Li JS
Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
